Gut Microbiome in Patients With Post-infectious Irritable Bowel Syndrome
A legfontosabb adatok
- Ki végzi
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Hol
- Rome (Olaszország)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 315 fő, tervezett
- Kezdés
- 2026. ápr. 8.
- Várható befejezés
- 2028. dec.
- A vizsgálat típusa
- Megfigyeléses, 3 csoport
- A regiszteradat frissítve
- 2026. április 13.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with irritable bowel syndrome that started after a gut infection (PI-IBS). It also wants two comparison groups: people who fully recovered from a gut infection without IBS, and healthy people.
- Életkor
- 18 years or older.
- Nem
- All sexes can join.
- A betegség stádiuma
- PI-IBS patients: diagnosed by Rome IV criteria, no earlier than 3 months before joining. Post-infection group: a sudden gut infection (gastroenteritis) more than 6 months before joining, with full recovery and no lasting gut symptoms. Healthy group: donors from a stool transplant (FMT) or blood donor program, with no gut or whole-body disorders.
- Korábbi kezelés
- Healthy group: no antibiotics or probiotics in the last 4 weeks, and no long-term medicines that change gut bacteria (for example PPI).
A részvétel fő kizáró okai
- PI-IBS patients: long-term gut diseases such as inflammatory bowel disease (IBD), or gut cancers.
- PI-IBS patients: metabolic syndrome, obesity, diabetes, or autoimmune diseases affecting the whole body.
- PI-IBS patients: past major surgery on the belly.
- Post-infection group: current or past IBS, or any long-term gut or whole-body disorder.
- Healthy group: any long-term gut or whole-body condition.
A regiszter feltételei, szó szerint
Mind a 7 feltétel megnézéseKevesebb
Egyéb feltételek
- PI-IBS patients (n = 105)
- Inclusion criteria; Age ≥ 18 years old; PI-IBS diagnosed according to Rome IV criteria (33); Diagnosis no earlier than 3 months before enrollment; Written informed consent and compliance with study procedures
- Exclusion criteria; Chronic organic gastrointestinal (GI) disorders (e.g. Inflammatory Bowel Disease -IBD), metabolic syndrome, obesity, diabetes, GI cancers, systemic autoimmune disorders; History of major abdominal surgery; Control cohort #1 - Post-infectious non-IBS (n = 105)
- Inclusion criteria; Age ≥ 18 years old; History of acute infectious gastroenteritis >6 months before enrollment; Complete recovery without persistent GI symptoms
- Exclusion criteria; Current or past diagnosis of IBS; Any chronic GI or systemic disorders; Control cohort #2 - Healthy subjects (n = 105)
- Inclusion criteria; Age ≥ 18 years old; Healthy donors from FMT program or blood donor program; No history of GI or systemic disorders
- Exclusion criteria; Any GI or systemic chronic condition; Recent antibiotics/probiotics (<4 weeks); Chronic medication affecting microbiome composition (e.g. PPI)
Helyszínek itt: Olaszország
- Digestive Disease Center, Fondazione Policlinico Univesitario A. Gemelli IRCCSRome, OlaszországContact: Gianluca Ianiro, MDRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
Observational, multicenter, prospective study aimed at characterizing the gut microbiome in patients with post-infectious irritable bowel syndrome (PI-IBS) using whole genome sequencing (WGS). The study will compare microbiome composition and function between PI-IBS patients and two control groups (post-infectious subjects without irritable bowel syndrome -IBS- and healthy controls), with the goal of identifying reproducible microbial signatures and target taxa associated with disease and symptom severity.
A vizsgálat 3 csoportja
- Post-infectious-IBS patients
Patients diagnosed with post-infectious irritable bowel syndrome (PI-IBS) according to Rome IV criteria. Participants must be ≥18 years old and diagnosed within 3 months prior to enrollment. Clinical data, including IBS severity scoring system (IBS-SSS), medical history, diet, and lifestyle factors will be collected. Stool samples will be collected at baseline and at monthly follow-up visits for 3 months.
- Post-infectious non-IBS controls
Adults ≥18 years old with a history of acute infectious gastroenteritis occurring more than 6 months prior to enrollment, with complete recovery and no persistent gastrointestinal symptoms or diagnosis of IBS. One stool sample and associated clinical and lifestyle data will be collected at enrollment.
- Healthy controls
Healthy adult subjects ≥18 years old with no history of gastrointestinal or systemic disorders, recruited from fecal microbiota transplantation (FMT) or blood donor programs. Participants must not have taken antibiotics or probiotics within 4 weeks prior to enrollment. One stool sample and associated demographic and lifestyle data will be collected at enrollment.
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Informed Ecological Rewiring of Gut Microbiome for Dysbiosis-associated Disorders
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. április 13.